Skip to content

Medical-device intelligence

NIY: Autoantibodies, Anti-Soluble Liver Antigen (Sla), Autoimmune Hepatitis

FDA product code NIY: Autoantibodies, Anti-Soluble Liver Antigen (Sla), Autoimmune Hepatitis. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NIY
FDA device name
Autoantibodies, Anti-Soluble Liver Antigen (Sla), Autoimmune Hepatitis
Device class
2
Regulation number
866.5660
Medical specialty
Immunology
Review panel
IM

FDA definition

ELISA for the detection of anti-SLA (soluble liver antigen) antibody of the IgG class. Intended to aid in the diagnosis of conditions with elevated levels of anti-SLA antibody including autoimmune hepatitis
Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

3 clearance records and 0 recall records in the covered releases, across 2 source company names and 1 product codes. Dated history runs from Jul 30, 2002 to Apr 12, 2013.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

3 matching records
Device / recordCompany in FDA recordSourceSource date
EUROIMMUN EUROLINE PROFILE AUTOIMMUNE LIVER DISEASE 8AG (IGG)K113439 · NIYEuroimmun US510(k)Apr 12, 2013FDA decision date
EUROIMMUN ANTI-SLA/LP ELISA(LGG)K112221 · NIYEuroimmun US510(k)Sep 11, 2012FDA decision date
QUANTA LITE SLA (SOLUBLE LIVER ANTIGEN) ELISAK021482 · NIYInova Diagnostics, Inc.510(k)Jul 30, 2002FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗